Lipid Panel Testing Market Growth Outlook Through 2024-2033

Overview and Scope
Lipid panel testing to a blood test that measuring the levels of various lipids or fats in the blood. It is used to assess a person’s risk of developing cardiovascular disease.

Sizing and Forecast
The lipid panel testing market size has grown strongly in recent years. It will grow from $10.28 billion in 2023 to $11.17 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increased incidence of cardiovascular diseases, growth in awareness of preventive healthcare, government initiatives for cardiovascular health, lifestyle changes and dietary patterns, aging population and chronic diseases.

The lipid panel testing market size is expected to see strong growth in the next few years. It will grow to $15.13 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to genetic testing and personalized medicine, focus on early detection and prevention, expansion of home testing kits, focus on value-based care models, increased screening in high-risk populations. Major trends in the forecast period include point-of-care testing, integration with electronic health records, genetic lipid testing, home-based testing kits, telemedicine integration, educational initiatives for lipid management.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Segmentation & Regional Insights
The lipid panel testing market covered in this report is segmented –

1) By Product And Services: Devices, Kits, Services
2) By Prescription Mode: Prescription-Based Testing, OTC-Based Testing
3) By Application: Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo-Lipoproteinamia, Tangier Disease, Atherosclerosis, Other Applications
4) By End User: Hospital, Specialty Clinics And Physician Offices, Pathology Laboratories, Diagnostic Clinics, Ambulatory Surgical Centers, Reference Laboratories, Academic And Research Institutes, Other End-Users

North America was the largest region in the lipid panel testing market in 2023. Asia-Pacific is expected to be the fastest growing region in the global lipid panel testing market during the forecast period. The regions covered in the lipid panel testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10270&type=smp

Major Driver Impacting Market Growth
The increasing number of cardiovascular and diabetic diseases is expected to boost the lipid panel testing market going forward. Cardiovascular disease is a group of conditions that affect the heart and blood vessels, whereas Diabetes is a metabolic disorder that affects the body’s ability to produce insulin effectively, leading to high blood sugar levels. Lipid panel testing is an essential diagnostic tool for identifying individuals at high risk of developing cardiovascular diseases or already developed cardiovascular disease. It is also be used to monitor the effectiveness of treatment in individuals who have already developed cardiovascular or diabetes disease, allowing healthcare providers to adjust treatment plans as needed to achieve target lipid levels and reduce the risk of another ailment. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 17.9 million deaths from cardiovascular diseases. Furthermore, in 2022, according to the Centers for Disease Control and Prevention (CDC) National Diabetes Statistics Report, a US-based government agency, diabetes cases in US is increased to reach 37.3 million in 2022. Therefore, improving cardiovascular and diabetic diseases will drive the lipid panel testing market forward.

Key Industry Players
Major companies operating in the lipid panel testing market report are Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., EuroMedix International, Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH , Avanti Polar Lipids Inc., Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, Grifols S.A., Hologic Inc., Illumina Inc., Luminex Corporation, Meridian Bioscience Inc., Myriad Genetics Inc., Natera Inc., Ortho Clinical Diagnostics LLC

The lipid panel testing market report table of contents includes:

1. Executive Summary
2. Lipid Panel Testing Market Characteristics
3. Lipid Panel Testing Market Trends And Strategies
4. Lipid Panel Testing Market – Macro Economic Scenario
5. Global Lipid Panel Testing Market Size and Growth
.
.
.
31. Global Lipid Panel Testing Market Competitive Benchmarking
32. Global Lipid Panel Testing Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Lipid Panel Testing Market
34. Lipid Panel Testing Market Future Outlook and Potential Analysis
35. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model